Raymond W Lam Selected Research

Seasonal Affective Disorder

10/2022	Blue-Light Therapy for Seasonal and Non-Seasonal Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
10/2015	Enhanced inflammatory and T-helper-1 type responses but suppressed lymphocyte proliferation in patients with seasonal affective disorder and treated by light therapy.
1/2012	Direct health care costs of treating seasonal affective disorder: a comparison of light therapy and fluoxetine.
8/2009	Evidence of a biological effect of light therapy on the retina of patients with seasonal affective disorder.
8/2007	A controlled trial of the Litebook light-emitting diode (LED) light therapy device for treatment of Seasonal Affective Disorder (SAD).
5/2007	Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the Can-SAD study.
5/2006	The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder.
1/2005	Therapeutic mechanism in seasonal affective disorder: do fluoxetine and light operate through advancing circadian phase?
12/2004	Treatment of seasonal affective disorder: unipolar versus bipolar differences.
6/2004	Electroretinography in patients with winter seasonal affective disorder.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raymond W Lam Research Topics

Disease

71	Major Depressive Disorder (Major Depressive Disorders) 11/2022 - 01/2003
26	Bipolar Disorder (Manic Depressive Psychosis) 06/2022 - 05/2002
17	Mania (Manias) 12/2021 - 05/2002
15	Treatment-Resistant Depressive Disorder 01/2022 - 08/2002
12	Seasonal Affective Disorder 10/2022 - 09/2002
8	Mood Disorders (Mood Disorder) 01/2021 - 06/2004
7	Mental Disorders (Mental Disorder) 01/2021 - 11/2006
4	Anxiety Disorders (Anxiety Disorder) 01/2021 - 01/2003
4	Cognitive Dysfunction 01/2020 - 05/2013
3	Depressive Disorder (Melancholia) 01/2021 - 11/2002
3	Anhedonia 01/2020 - 01/2012
3	Sleep Deprivation 12/2019 - 10/2009
3	Fatigue 11/2017 - 01/2003
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 11/2020
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021 - 02/2012
2	Hypertension (High Blood Pressure) 01/2021 - 03/2015
2	Nausea 01/2020 - 01/2003
2	Confusion (Bewilderment) 01/2017 - 03/2015
2	Weight Gain 07/2010 - 01/2003
1	Pain (Aches) 01/2022
1	Inflammation (Inflammations) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Tobacco Use Disorder (Nicotine Dependence) 01/2021
1	Genetic Risk Score 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Schizophrenia (Dementia Praecox) 01/2021
1	Tourette Syndrome (Tourette's Syndrome) 01/2021
1	Anorexia Nervosa 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Stroke (Strokes) 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2021
1	Overweight 01/2020
1	Syndrome (Syndromes) 01/2020
1	Psychotic Disorders (Schizoaffective Disorder) 01/2018

Drug/Important Bio-Agent (IBA)

41	Antidepressive Agents (Antidepressants)IBA 01/2022 - 08/2002
19	Escitalopram FDA Link 01/2022 - 03/2006
14	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 05/2002
12	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2018
9	Aripiprazole (Abilify)FDA Link 01/2022 - 01/2018
8	Fluoxetine (Prozac)FDA LinkGeneric 01/2022 - 01/2005
8	Valproic Acid (Depakote)FDA LinkGeneric 12/2021 - 05/2002
7	Desvenlafaxine Succinate FDA Link 01/2022 - 09/2014
7	Ketamine FDA LinkGeneric 01/2022 - 03/2015
5	Biological ProductsIBA 01/2021 - 08/2009
4	salicylhydroxamic acid (SHAM)IBA 01/2021 - 09/2008
4	LithiumIBA 01/2020 - 06/2013
4	Pharmaceutical PreparationsIBA 10/2018 - 01/2010
3	Glutamic Acid (Glutamate)FDA Link 03/2021 - 08/2012
3	Glutamine (L-Glutamine)FDA Link 03/2021 - 08/2012
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2020 - 03/2006
3	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2019 - 07/2010
3	Quetiapine Fumarate (Seroquel)FDA Link 01/2018 - 10/2010
2	asenapine FDA Link 12/2021 - 01/2018
2	cariprazineIBA 12/2021 - 01/2018
2	CannabinoidsIBA 01/2021 - 01/2021
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2019 - 07/2008
2	Therapeutic UsesIBA 01/2019 - 12/2004
2	Protons (Proton)IBA 02/2016 - 08/2012
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2016 - 10/2009
2	S-Adenosylmethionine (Ademetionine)IBA 01/2016 - 10/2009
2	Serotonin (5 Hydroxytryptamine)IBA 07/2010 - 01/2010
2	setoperoneIBA 06/2010 - 01/2010
2	Retinaldehyde (Retinal)IBA 08/2009 - 06/2004
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2009 - 02/2009
2	Citalopram FDA LinkGeneric 10/2008 - 03/2004
2	Bupropion (Wellbutrin)FDA LinkGeneric 10/2008 - 03/2004
2	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 10/2008 - 03/2006
2	Mirtazapine (Rexer)FDA LinkGeneric 10/2008 - 01/2003
2	Oxcarbazepine (Trileptal)FDA LinkGeneric 07/2006 - 01/2005
2	Neurotransmitter Agents (Neurotransmitter)IBA 06/2004 - 01/2004
2	Dopamine (Intropin)FDA LinkGeneric 10/2002 - 05/2002
1	EndocannabinoidsIBA 11/2022
1	mesoglycanIBA 06/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2022
1	N-acetylaspartate (N-acetyl aspartate)IBA 03/2021
1	Long Noncoding RNAIBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	Excipients (Suspending Agents)IBA 01/2021
1	UbiquitinIBA 01/2021
1	BenzodiazepinesIBA 01/2020
1	Epidermal Growth Factor (EGF)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 10/2018
1	propylene diquat (PDQ(+))IBA 01/2018
1	O-methyl reboxetineIBA 01/2018
1	Paliperidone Palmitate FDA Link 01/2018
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2018
1	lipoarabinomannan (LAM)IBA 11/2017
1	Lipocalin-2IBA 04/2017

Therapy/Procedure

20	Therapeutics 01/2022 - 11/2002
16	Phototherapy (Light Therapy) 10/2022 - 09/2002
8	Transcranial Magnetic Stimulation 11/2021 - 09/2008
5	Drug Therapy (Chemotherapy) 01/2021 - 12/2004
4	Deep Brain Stimulation 11/2017 - 10/2009
3	Complementary Therapies (Alternative Medicine) 01/2018 - 10/2009
1	Chronotherapy 12/2019